Citadel Advisors
SPPI

Citadel Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Citadel Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-116,700
Closed -$112K – 15575
2023
Q2 		$112K Sell
116,700
-16,600
-12% -$16.4K ﹤0.01% 10754
2023
Q1 		$100K Sell
133,300
-50,400
-27% -$36.8K ﹤0.01% 11262
2022
Q4 		$67.7K Sell
183,700
-5,400
-3% -$2.28K ﹤0.01% 11751
2022
Q3 		$81K Buy
189,100
+73,400
+63% +$72.1K ﹤0.01% 11279
2022
Q2 		$90K Buy
115,700
+30,200
+35% +$26.6K ﹤0.01% 11511
2022
Q1 		$110K Buy
85,500
+51,500
+151% +$47.4K ﹤0.01% 12188
2021
Q4 		$43K Sell
34,000
-107,800
-76% -$193K ﹤0.01% 13330
2021
Q3 		$309K Buy
141,800
+99,900
+238% +$273K ﹤0.01% 11022
2021
Q2 		$157K Buy
41,900
+13,200
+46% +$45.9K ﹤0.01% 12454
2021
Q1 		$94K Buy
28,700
+8,200
+40% +$29.4K ﹤0.01% 12524
2020
Q4 		$70K Sell
20,500
-45,700
-69% -$188K ﹤0.01% 10421
2020
Q3 		$270K Buy
66,200
+42,800
+183% +$163K ﹤0.01% 8314
2020
Q2 		$79K Sell
23,400
-26,000
-53% -$75.8K ﹤0.01% 9116
2020
Q1 		$115K Sell
49,400
-69,300
-58% -$190K ﹤0.01% 8536
2019
Q4 		$432K Buy
118,700
+69,800
+143% +$564K ﹤0.01% 7041
2019
Q3 		$406K Buy
48,900
+35,800
+273% +$290K ﹤0.01% 7106
2019
Q2 		$113K Sell
13,100
-4,200
-24% -$37.6K ﹤0.01% 8492
2019
Q1 		$185K Sell
17,300
-2,000
-10% -$21.4K ﹤0.01% 8258
2018
Q4 		$169K Sell
19,300
-89,700
-82% -$1.14M ﹤0.01% 7988
2018
Q3 		$1.83M Buy
109,000
+65,900
+153% +$1.43M ﹤0.01% 4564
2018
Q2 		$903K Buy
43,100
+12,500
+41% +$232K ﹤0.01% 5397
2018
Q1 		$492K Sell
30,600
-8,000
-21% -$158K ﹤0.01% 5911
2017
Q4 		$731K Buy
38,600
+6,700
+21% +$121K ﹤0.01% 5100
2017
Q3 		$449K Buy
+31,900
New +$289K ﹤0.01% 5482
2017
Q2 		– Sell
-11,800
Closed -$77K – 8241
2017
Q1 		$77K Sell
11,800
-6,900
-37% -$38.6K ﹤0.01% 6940
2016
Q4 		$83K Sell
18,700
-14,100
-43% -$59.1K ﹤0.01% 6740
2016
Q3 		$153K Buy
32,800
+16,700
+104% +$98.9K ﹤0.01% 6455
2016
Q2 		$106K Sell
16,100
-4,400
-21% -$31.1K ﹤0.01% 6165
2016
Q1 		$130K Buy
20,500
+11,600
+130% +$59.5K ﹤0.01% 5905
2015
Q4 		$54K Sell
8,900
-11,800
-57% -$67.5K ﹤0.01% 7251
2015
Q3 		$124K Buy
20,700
+2,900
+16% +$20.1K ﹤0.01% 6744
2015
Q2 		$122K Sell
17,800
-4,100
-19% -$26K ﹤0.01% 6889
2015
Q1 		$133K Buy
21,900
+16,100
+278% +$107K ﹤0.01% 6605
2014
Q4 		$40K Sell
5,800
-8,600
-60% -$63.2K ﹤0.01% 7365
2014
Q3 		$117K Buy
14,400
+2,400
+20% +$18.8K ﹤0.01% 6263
2014
Q2 		$98K Buy
12,000
+400
+3% +$3.04K ﹤0.01% 6248
2014
Q1 		$91K Sell
11,600
-7,500
-39% -$63.5K ﹤0.01% 6285
2013
Q4 		$169K Sell
19,100
-5,100
-21% -$45.6K ﹤0.01% 5191
2013
Q3 		$203K Sell
24,200
-20,400
-46% -$165K ﹤0.01% 4748
2013
Q2 		$333K Buy
+44,600
New +$342K ﹤0.01% 4203

Citadel Advisors's SPPI Position: Q3 2023 in Review

Citadel Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 100 shares — an estimated $96 sold.

Citadel Advisors first reported a position in SPPI in Q2 2013 and held it in 35 quarters. The position peaked at $26.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Citadel Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • Citadel Advisors sold 100 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $96.
  • Citadel Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
  • Citadel Advisors's Spectrum Pharmaceuticals Inc position peaked at $26.5M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.